Castration-Resistant Prostate Cancer: Mechanisms, Targets and Treatment

被引：81
|
作者：
Mansinho, Andre [1 ]
Macedo, Daniela [1 ]
Fernandes, Isabel [1 ,2 ]
Costa, Luis [1 ,2 ]
机构：
[1] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Dept Oncol, Lisbon, Portugal
[2] Inst Med Mol, Fac Med Lisboa, Div Oncol, Lisbon, Portugal
来源：
MOLECULAR & DIAGNOSTIC IMAGING IN PROSTATE CANCER: CLINICAL APPLICATIONS AND TREATMENT STRATEGIES | 2019年 / 1126卷
关键词：
INCREASED SURVIVAL; DOUBLE-BLIND; PHASE-III; DOCETAXEL; THERAPY; CABAZITAXEL; PREDNISONE; ENZALUTAMIDE; MITOXANTRONE; ABIRATERONE;
D O I：
10.1007/978-3-319-99286-0_7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：117 / 133
页数：17
相关论文
共 50 条
  • [41] Talazoparib for the Treatment of Metastatic Castration-resistant Prostate Cancer
    Qureshi, Zaheer
    Fatima, Eeshal
    Safi, Adnan
    Khanzada, Mikail
    Altaf, Faryal
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2025, 48 (04): : 206 - 214
  • [42] Targeting treatment options for castration-resistant prostate cancer
    Miller, Dannah R.
    Ingersoll, Matthew A.
    Teply, Benjamin A.
    Lin, Ming-Fong
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2021, 9 (01): : 101 - 120
  • [43] Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
    Rodriguez-Vida, Alejo
    Galazi, Myria
    Rudman, Sarah
    Chowdhury, Simon
    Sternberg, Cora N.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3325 - 3339
  • [44] Perspectives on Treatment of Metastatic Castration-Resistant Prostate Cancer
    Merseburger, Axel S.
    Bellmunt, Joaquim
    Jenkins, Cheryl
    Parker, Chris
    Fitzpatrick, John M.
    ONCOLOGIST, 2013, 18 (05): : 558 - 567
  • [45] A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer
    Crowley, Fionnuala
    Sterpi, Michelle
    Buckley, Conor
    Margetich, Lauren
    Handa, Shivani
    Dovey, Zach
    RESEARCH AND REPORTS IN UROLOGY, 2021, 13 : 457 - 472
  • [46] Adaptation or selection-mechanisms of castration-resistant prostate cancer
    Zong, Yang
    Goldstein, Andrew S.
    NATURE REVIEWS UROLOGY, 2013, 10 (02) : 90 - 98
  • [47] Mechanisms of Androgen Receptor Activation in Castration-Resistant Prostate Cancer
    Sharifi, Nima
    ENDOCRINOLOGY, 2013, 154 (11) : 4010 - 4017
  • [48] Darolutamide For Castration-Resistant Prostate Cancer
    Bastos, Diogo A.
    Antonarakis, Emmanuel S.
    ONCOTARGETS AND THERAPY, 2019, 12 : 8769 - 8777
  • [49] Immunotherapy for Castration-Resistant Prostate Cancer
    Sonpavde, Guru
    Kantoff, Philip W.
    UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : 465 - +
  • [50] Chemotherapy for castration-resistant prostate cancer
    Berthold, D.
    ONKOLOGIE, 2011, 34 : 12 - 12
12345